But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS ... discuss the array of existing and emerging classes of drugs that could benefit those with ACOS and share their ...

The Dr Trust Bestest Compressor Nebulizer is a highly efficient and reliable device for home use. It features a powerful ...